Nrf2-Dependent Expression of Glutathione Antioxidant System Genes and Redox Status in Cells of In Vivo Drug-Resistant Murine P388 Leukemia Strains

Bull Exp Biol Med. 2020 Jun;169(2):249-253. doi: 10.1007/s10517-020-04861-2. Epub 2020 Jul 10.

Abstract

We measured the content of ROS and malondialdehyde in cells of in vivo drug-resistant murine P388 leukemia strains. It was found that the strains did not differ by malondialdehyde concentration, but intracellular concentration of ROS in cells of the cyclophosphamide-resistant strain (P388/CP) was higher than in cells of the original (P388) and other studied strains (P388/Rub, P388/cPt). Nuclear localization of the transcription factor Nrf2 in cells of strain P388/CP attested to its constitutive activation. Enhanced relative expression of the GCLM gene was found in all studied drug-resistant strains; the expression of the GSR and GPX1 genes was increased only in cells of the cyclophosphamide-resistant strain. These findings suggest that the mechanism of resistance of strain P388/CP is associated with increased activity of glutathione metabolism that developed as a result of activation of the antioxidant response transcription factor Nrf2 against the background of high intracellular concentration of ROS.

Keywords: antioxidant system; drug resistance mechanism; glutathione; murine P388 leukemia; transcription factor Nrf2.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Cell Line, Tumor
  • Cyclophosphamide / metabolism
  • Glutathione / metabolism*
  • Malondialdehyde / metabolism
  • Mice
  • NF-E2-Related Factor 2 / metabolism*
  • Oxidation-Reduction
  • Reactive Oxygen Species / metabolism

Substances

  • Antioxidants
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Reactive Oxygen Species
  • Malondialdehyde
  • Cyclophosphamide
  • Glutathione